Multiple reporter read-out for bioassays

• US 7,465,540 B2
• Filed: 09/21/2001
• Issued: 12/16/2008
• Est. Priority Date: 09/21/2000
• Status: Expired due to Term

• Current Assignee: Luminex Corporation (DiaSorin S.p.A.)
• Original Assignee: Luminex Corporation (DiaSorin S.p.A.)
• Inventors: Oliver, Kerry G., Jacobson, James W., Burroughs, Jennifer L.
• Primary Examiner(s): Horlick; Kenneth R.
• Application Number:
  US09/956,857
• Publication Number:
  US 20030054356A1
• Time in Patent Office: 2,643 Days
• Field of Search: 435/6, 435/91.2, 536/23.1, 536/24.3
• US Class Current: 506/4
• CPC Class Codes: C12Q 1/6827 for detection of mutation or polymorphism
• CPC Class Codes: C12Q 2537/143 Multiplexing, i.e. use of multiple primers or probes in a single reaction, usually for simultaneously analyse of multiple analysis
• CPC Class Codes: C12Q 2563/107 fluorescence
• CPC Class Codes: C12Q 2565/501 being an array of oligonucleotides
• CPC Class Codes: G01N 33/54313 the carrier being characterised by its particulate form
• CPC Class Codes: Y02A 50/30 Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Abstract

A method for detecting a plurality of reactive sites on an analyte, comprising allowing reactants on an addressable microsphere and the reactive sites to react, forming reactant-reactive site pairs distinguishable by fluorescence intensity. The invention also provides a method for detecting a plurality of analytes in a sample using addressable microspheres in combination with one or more reporter reagents. Also provided are a method for determining allele zygosity of a genetic locus having two alleles or more alleles using microparticles, and a method for detecting a plurality of SNPs in nucleic acid molecules. The instant invention also provides a composition comprising an addressable microsphere carrying at least two fluorescent reactants capable of forming reactant-analyte pairs distinguishable by their fluorescence intensity, and kits comprising the inventive composition and a plurality of reporter reagents.

Claims

1. A method for detection of different reactive sites on at least one analyte, the method comprising:

(1) providing a population of microspheres, wherein each of the microspheres carries different reactants capable of reacting respectively with the different reactive sites, wherein the at least one analyte comprises a nucleic acid molecule, wherein the different reactive sites comprise one or more alleles of a locus on the nucleic acid molecule, and wherein the different reactants comprise one or more fluorescently-labeled nucleic acid probes respectively specific for the one or more alleles;

(2) allowing the different reactants and the different reactive sites to react, thereby forming reactant-reactive site pairs on the microspheres, wherein different reactant-reactive site pairs are detectably distinguishable from each other by their fluorescence intensity, and wherein the different reactant-reactive site pairs are not detectably distinguishable from each other by their fluorescence wavelength; and

(3) detecting the fluorescence intensity of the reactant-reactive site pairs formed on one of the microspheres simultaneously, whereby the presence or absence of each of the different reactive sites on the at least one analyte is determined based on the fluorescence intensity of the reactant-reactive site pairs.

2. The method of claim 1, wherein the fluorescence intensity of the reactant-reactive site pairs is detected using flow cytometry.

3. The method of claim 1, wherein the nucleic acid molecule has been subject to in vitro manipulation.

4. The method of claim 3, wherein the in vitro manipulation is a PCR amplification, a restriction enzyme digestion, strand displacement amplification (SDA), transcription mediated amplification (TMA), ligase chain reaction (LCR), nucleic acid sequence based amplification (NASBA), primer extension, rolling circle amplification, amplification of RNA by an RNA-directed RNA polymerase, or a combination thereof.

5. A method for determining allele zygosity of nucleic acid molecules of a genetic locus having two alleles, the method comprising:

(1) providing a population of microspheres, wherein each of the microspheres carries two different nucleic acid probes respectively specific to each of the two alleles;

(2) allowing the probes to hybridize to the two alleles, thereby forming allele-probe pairs on the microspheres, wherein different allele-probe pairs are detectably distinguishable by their fluorescence intensity, and wherein the different allele-probe pairs are not detectably distinguishable by their fluorescence wavelength; and

(3) detecting the fluorescence intensity of the allele-probe pairs formed on one or the microspheres simultaneously, whereby the allele zygosity of the genetic locus is determined based on the fluorescence intensity of the allele-probe pairs.

6. A method for determining polymorphism of nucleic acid molecules of a genetic locus having multiple alleles, the method comprising:

(1) providing a population of microspheres, wherein each of the microspheres carries multiple different nucleic acid probes respectively specific to each of the multiple alleles;

(2) allowing the probes to hybridize to the multiple alleles, thereby forming allele-probe pairs on microspheres, wherein different allele-probe pairs are distinguishable by fluorescence intensity, and wherein the different allele-probe pairs are not distinguishable by fluorescence wavelength; and

(3) detecting the fluorescence intensity of the allele-probe pairs formed on one of the microspheres simultaneously, whereby the allele polymorphism of the genetic locus is determined based on the fluorescence intensity of the allele-probe pairs.

7. The method of claim 6, wherein the genetic locus is the human BRCA1 gene.

8. The method of claim 6, wherein the nucleic acid molecules comprise a mixture of nucleic acid molecules from more than one organism.

9. A method for detecting different analytes in a sample, the method comprising:

(1) providing a population of microspheres, wherein each of the microspheres carries different reactants capable of reacting respectively to each of the different analytes;

(2) allowing the reactant and the analytes to react, thereby forming reactant-analyte pairs;

(3) providing a mixture of reporter reagents capable of reacting with the reactant-analyte pairs;

(4) allowing the reporter reagents to react with the reactant-analyte pairs to form reactant-analyte-reporter reagent complexes, wherein different reactant-analyte-reporter reagent complexes are distinguishable by fluorescence intensity, but not by fluorescence wavelength, wherein the analytes are alleles of target nucleic acid molecules of a genetic locus, wherein the reactants are capture probes complementary to a common sequence within the genetic locus, and wherein the reporter reagents are reporter probes specific to the individual alleles; and

(5) detecting the fluorescence intensity of the reactant-analyte-reporter reagent complexes formed on one of the microspheres simultaneously, whereby the presence or absence of each of the different analytes is determined based on the fluorescence intensity.

10. The method of claim 9, wherein the capture probes abut their respective reporter probes, wherein the reactant-analyte-reporter reagent complexes are formed via oligonucleotide ligation assay, and wherein the fluorescence intensity is analyzed using a flow cytometer.

11. The method of claim 9, further comprising heating the complexes to remove the target nucleic acid molecule between steps (4) and (5).

12. A method for detecting SNPs in target nucleic acid molecules, wherein each of the SNPs has two or more polymorphisms, the method comprising:

(1) providing a plurality of populations of microspheres, wherein each population corresponds to one of the SNPs and has an addressable signature, and wherein each of the microspheres in a population carries two or more nucleic acid probes specific respectively to each of the polymorphisms for the SNP;

(2) allowing the probes to hybridize to the SNPs, thereby forming SNP-probe pairs, wherein different SNP-probe pairs are distinguishable by fluorescence intensity but not by fluorescence wavelength; and

(3) determining the type of SNPs via detecting the fluorescence intensity of the SNP-probe pairs formed on one of the microspheres simultaneously, and detecting the addressable signature.

13. The method of claim 12, further comprising fragmenting the nucleic acid molecules.

14. A method for detecting different reactive sites on an analyte, comprising:

allowing different reactants to react with the different reactive sites on the analyte to form one or more reactant-reactive site pairs, wherein the different reactants are carried on a microsphere, and wherein each of the different reactants is capable of reacting specifically with one of the different reactive sites;

analyzing the microsphere to detect output signal responsive to each of the reactant-reactive site pairs, formed on the microsphere, wherein different reactant-reactive site pairs are distinguishable by their fluorescence intensity but not by their fluorescence wavelength;

determining which of the reactant-reactive site pairs were formed using the output signal; and

determining which of the different reactive sites are present on the analyte using results of said determining, wherein a determination that a reactant-reactive site pair was formed indicates a presence of the reactive site, corresponding to the formed reactant-reactive site pair, on the analyte.

15. The method of claim 14, wherein the different reactants are fluorescently-labeled.

16. The method of claim 14, wherein the different reactive sites are fluorescently-labeled.

17. The method of claim 14, wherein said analyzing is performed using flow cytometry.

18. The method of claim 14, wherein the analyte is a nucleic acid molecule, wherein the different reactive sites comprise two or more alleles of a locus on the nucleic acid molecule, and wherein the different reactants comprise two or more fluorescently-labeled nucleic acid probes respectively specific for the two or more alleles.

19. The method of claim 18, wherein the nucleic acid molecule has been subject to in vitro manipulation.

20. The method of claim 19, wherein the in vitro manipulation is a PCR amplification, a restriction enzyme digestion, strand displacement amplification (SDA), transcription mediated amplification (TMA), ligase chain reaction (LCR), nucleic acid sequence based amplification (NASBA) primer extension, rolling circle amplification, amplification of RNA by an RNA-directed RNA polymerase, or a combination thereof.

21. The method of claim 14, wherein the analyte is an antigen molecule, wherein the different reactive sites comprise two or more epitopes on the antigen molecule, and wherein the different reactants comprise two or more fluorescently-labeled antibodies respectively specific for the two or more epitopes.

22. The method of claim 14, wherein the analyte is a human chorionic gonadotropin (hCG) related molecule, wherein the different reactive sites comprise a alpha-subunit or a variant thereof or a beta-subunit or a variant thereof, and wherein the different reactants comprise a respective antibody.

23. A method for detecting different analytes in a sample, comprising:

allowing different reactants to react with the different analytes to form one or more reactant-analyte pairs, wherein the different reactants are carried on a microsphere, and wherein each of the different reactants are capable of reacting specifically with one of the different analytes;

allowing reporter reagents to react with the one or more reactant-analyte pairs to form reactant-analyte-reporter reagent complexes;

analyzing the microsphere to detect an output signal responsive to each of the complexes formed on the microsphere, wherein different complexes are distinguishable by their fluorescence intensity but not by their fluorescence wavelength;

determining which of the complexes were formed using the output signal; and

determining which of the different analytes are present in the sample using results of said determining, wherein a determination that a complex was formed indicates a presence of the analyte, corresponding to the formed complex, in the sample.

24. The method of claim 23, wherein the different analytes comprise immunoglobulins, wherein the different reactants comprise antigens that bind to the immunoglobulins, and wherein the reporter agents comprise fluorescently-labeled anti-immunoglobulin antibodies.

25. The method of claim 24, wherein the antigens comprise insulin.

26. The method of claim 23, wherein the different analytes comprise alleles of target nucleic acid molecules of a genetic locus, wherein the different reactants comprise capture probes complementary to a common sequence within the genetic locus, and wherein the reporter reagents comprise reporter probes specific to the individual alleles.

27. The method of claim 26, wherein the capture probes abut their respective reporter probes, wherein the reactant-analyte-reporter reagent complexes are formed via oligonucleotide ligation assay, and wherein the complexes are analyzed using a flow cytometer.

28. The method of claim 26, further comprising heating the complexes to remove the target nucleic acid molecules prior to said analyzing.